ArticleCancer medicine2026
Cancer-Directed Therapy in the Last Month of Life and Its Association With ICU Utilisation in a Tertiary Care Centre in India.
Article in Cancer medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundUse of cancer-directed therapies (CDT) near the end of life is an established indicator of quality in oncology care. However, evidence from low- and middle-income countries (LMICs), including India, remains limited.
objectivesTo describe patterns of cancer-directed therapy use in the last month of life and to evaluate the association between palliative care referral and ICU utilisation.
methodsThis retrospective cohort study included adult cancer patients who died in hospital between August 2020 and July 2023 and received at least one CDT within the LMOL. Data were extracted using a standardised proforma. The primary outcome was the pattern and timing of CDT use. Secondary outcomes included ICU utilisation, palliative care referral and documentation of end-of-life care processes. Associations between palliative care referral and ICU utilisation were evaluated using unadjusted odds ratios.
resultsAmong 4211 in-hospital deaths, 669 patients had cancer, of whom 384 received CDT in the LMOL and were included. Chemotherapy was the most common modality (58.3%). CDT was administered within 14, 7 and 3 days of death in 72.3%, 45.0% and 23.4% of patients, respectively. ICU admission occurred in 62.7%. Palliative care referral was documented in 76.8% of cases, though often late. Patients with a palliative care referral had significantly lower odds of ICU admission than those without referral (OR 0.07, 95% CI 0.03-0.18, p < 0.001). End-of-life care documentation was present in 40.6% of cases.
conclusionsHigh-intensity care near the end of life, including frequent CDT use and ICU admission, remains common in this LMIC setting. Palliative care referral was strongly associated with lower ICU utilisation, suggesting a potential association that warrants further investigation in prospective studies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.